Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Sep;50(Suppl 1):S53–S58. doi: 10.1136/thx.50.suppl_1.s53

Oxidants/antioxidants in idiopathic pulmonary fibrosis.

W MacNee 1, I Rahman 1
PMCID: PMC1129017  PMID: 7570466

Full text

PDF
S53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agustí C., Xaubet A., Roca J., Agustí A. G., Rodriguez-Roisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax. 1992 Dec;47(12):1035–1040. doi: 10.1136/thx.47.12.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aruoma O. I., Halliwell B., Hoey B. M., Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6(6):593–597. doi: 10.1016/0891-5849(89)90066-x. [DOI] [PubMed] [Google Scholar]
  3. Borgström L., Kågedal B., Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol. 1986;31(2):217–222. doi: 10.1007/BF00606662. [DOI] [PubMed] [Google Scholar]
  4. Borok Z., Buhl R., Grimes G. J., Bokser A. D., Hubbard R. C., Holroyd K. J., Roum J. H., Czerski D. B., Cantin A. M., Crystal R. G. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet. 1991 Jul 27;338(8761):215–216. doi: 10.1016/0140-6736(91)90350-x. [DOI] [PubMed] [Google Scholar]
  5. Borzì R. M., Grigolo B., Meliconi R., Fasano L., Sturani C., Fabbri M., Porstmann T., Facchini A. Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis. Clin Sci (Lond) 1993 Sep;85(3):353–359. doi: 10.1042/cs0850353. [DOI] [PubMed] [Google Scholar]
  6. Bridgeman M. M., Marsden M., MacNee W., Flenley D. C., Ryle A. P. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax. 1991 Jan;46(1):39–42. doi: 10.1136/thx.46.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bridgeman M. M., Marsden M., Selby C., Morrison D., MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax. 1994 Jul;49(7):670–675. doi: 10.1136/thx.49.7.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bridges A. B., Scott N. A., Parry G. J., Belch J. J. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med. 1993 Apr;2(4):205–208. [PubMed] [Google Scholar]
  9. Cantin A. M., Hubbard R. C., Crystal R. G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1989 Feb;139(2):370–372. doi: 10.1164/ajrccm/139.2.370. [DOI] [PubMed] [Google Scholar]
  10. Cantin A. M., Larivée P., Bégin R. O. Extracellular glutathione suppresses human lung fibroblast proliferation. Am J Respir Cell Mol Biol. 1990 Jul;3(1):79–85. doi: 10.1165/ajrcmb/3.1.79. [DOI] [PubMed] [Google Scholar]
  11. Cantin A. M., North S. L., Fells G. A., Hubbard R. C., Crystal R. G. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest. 1987 Jun;79(6):1665–1673. doi: 10.1172/JCI113005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cantin A. M., North S. L., Hubbard R. C., Crystal R. G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol (1985) 1987 Jul;63(1):152–157. doi: 10.1152/jappl.1987.63.1.152. [DOI] [PubMed] [Google Scholar]
  13. Carrington C. B., Gaensler E. A., Coutu R. E., FitzGerald M. X., Gupta R. G. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med. 1978 Apr 13;298(15):801–809. doi: 10.1056/NEJM197804132981501. [DOI] [PubMed] [Google Scholar]
  14. Cherniack R. M., Crystal R. G., Kalica A. R. NHLBI Workshop summary. Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis. 1991 Mar;143(3):680–683. doi: 10.1164/ajrccm/143.3.680. [DOI] [PubMed] [Google Scholar]
  15. Cotgreave I. A., Eklund A., Larsson K., Moldéus P. W. No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis. 1987 Feb;70(2):73–77. [PubMed] [Google Scholar]
  16. Cross C. E., van der Vliet A., O'Neill C. A., Louie S., Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect. 1994 Dec;102 (Suppl 10):185–191. doi: 10.1289/ehp.94102s10185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984 Jan 19;310(3):154–166. doi: 10.1056/NEJM198401193100304. [DOI] [PubMed] [Google Scholar]
  18. Dreisin R. B., Schwarz M. I., Theofilopoulos A. N., Stanford R. E. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med. 1978 Feb 16;298(7):353–357. doi: 10.1056/NEJM197802162980701. [DOI] [PubMed] [Google Scholar]
  19. Gauldie J., Jordana M., Cox G. Cytokines and pulmonary fibrosis. Thorax. 1993 Sep;48(9):931–935. doi: 10.1136/thx.48.9.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Grigolo B., Borzì R. M., Fasano L., Fabbri M., Meliconi R., Facchini A. Superoxide dismutases in idiopathic pulmonary fibrosis. Clin Sci (Lond) 1995 Mar;88(3):371–371. doi: 10.1042/cs0880371. [DOI] [PubMed] [Google Scholar]
  21. Halliwell B., Gutteridge J. M., Cross C. E. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992 Jun;119(6):598–620. [PubMed] [Google Scholar]
  22. Hunninghake G. W., Gadek J. E., Lawley T. J., Crystal R. G. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1981 Jul;68(1):259–269. doi: 10.1172/JCI110242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Johnson M. A., Kwan S., Snell N. J., Nunn A. J., Darbyshire J. H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989 Apr;44(4):280–288. doi: 10.1136/thx.44.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Johnston I. D., Gomm S. A., Kalra S., Woodcock A. A., Evans C. C., Hind C. R. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J. 1993 Jun;6(6):891–893. [PubMed] [Google Scholar]
  25. Jones J. G., Royston D., Minty B. D. Changes in alveolar-capillary barrier function in animals and humans. Am Rev Respir Dis. 1983 May;127(5 Pt 2):S51–S59. [PubMed] [Google Scholar]
  26. Lannan S., Donaldson K., Brown D., MacNee W. Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am J Physiol. 1994 Jan;266(1 Pt 1):L92–100. doi: 10.1152/ajplung.1994.266.1.L92. [DOI] [PubMed] [Google Scholar]
  27. Li X. Y., Donaldson K., Rahman I., MacNee W. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med. 1994 Jun;149(6):1518–1525. doi: 10.1164/ajrccm.149.6.8004308. [DOI] [PubMed] [Google Scholar]
  28. Marcy T. W., Merrill W. W., Rankin J. A., Reynolds H. Y. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1987 Jun;135(6):1276–1280. doi: 10.1164/arrd.1987.135.6.1276. [DOI] [PubMed] [Google Scholar]
  29. Meyer A., Buhl R., Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J. 1994 Mar;7(3):431–436. doi: 10.1183/09031936.94.07030431. [DOI] [PubMed] [Google Scholar]
  30. Meyer A., Magnussen H. Der Effekt von oralem N-Acetylcystein auf die Glutathion-Konzentration in der bronchoalveolären Lavage von Patienten mit fibrosierenden Lungenerkrankungen. Med Klin (Munich) 1991 Jun 15;86(6):279–283. [PubMed] [Google Scholar]
  31. Moolman J. A., Bardin P. G., Rossouw D. J., Joubert J. R. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax. 1991 Aug;46(8):592–595. doi: 10.1136/thx.46.8.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Munday R. Toxicity of thiols and disulphides: involvement of free-radical species. Free Radic Biol Med. 1989;7(6):659–673. doi: 10.1016/0891-5849(89)90147-0. [DOI] [PubMed] [Google Scholar]
  33. Pham Huu T., Marquetty C., Amit N., Hakim J. Effect of degranulation on superoxide dismutase activity in human neutrophils. J Free Radic Biol Med. 1986;2(3):213–217. doi: 10.1016/s0748-5514(86)80072-1. [DOI] [PubMed] [Google Scholar]
  34. Phan S. H., Gannon D. E., Ward P. A., Karmiol S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am J Respir Cell Mol Biol. 1992 Mar;6(3):270–278. doi: 10.1165/ajrcmb/6.3.270. [DOI] [PubMed] [Google Scholar]
  35. Phan S. H. New strategies for treatment of pulmonary fibrosis. Thorax. 1995 Apr;50(4):415–421. doi: 10.1136/thx.50.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Puri R. N., Meister A. Transport of glutathione, as gamma-glutamylcysteinylglycyl ester, into liver and kidney. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5258–5260. doi: 10.1073/pnas.80.17.5258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rennard S. I., Basset G., Lecossier D., O'Donnell K. M., Pinkston P., Martin P. G., Crystal R. G. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) 1986 Feb;60(2):532–538. doi: 10.1152/jappl.1986.60.2.532. [DOI] [PubMed] [Google Scholar]
  38. Rinderknecht J., Shapiro L., Krauthammer M., Taplin G., Wasserman K., Uszler J. M., Effros R. M. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis. 1980 Jan;121(1):105–117. doi: 10.1164/arrd.1980.121.1.105. [DOI] [PubMed] [Google Scholar]
  39. Smilkstein M. J., Knapp G. L., Kulig K. W., Rumack B. H. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) N Engl J Med. 1988 Dec 15;319(24):1557–1562. doi: 10.1056/NEJM198812153192401. [DOI] [PubMed] [Google Scholar]
  40. Stack B. H., Choo-Kang Y. F., Heard B. E. The prognosis of cryptogenic fibrosing alveolitis. Thorax. 1972 Sep;27(5):535–542. doi: 10.1136/thx.27.5.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Strausz J., Müller-Quernheim J., Steppling H., Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1990 Jan;141(1):124–128. doi: 10.1164/ajrccm/141.1.124. [DOI] [PubMed] [Google Scholar]
  42. Strieter R. M., Lukacs N. W., Standiford T. J., Kunkel S. L. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax. 1993 Jul;48(7):765–769. doi: 10.1136/thx.48.7.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980 Aug;35(8):593–599. doi: 10.1136/thx.35.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ward P. A., Duque R. E., Sulavik M. C., Johnson K. J. In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Production of O-2 and H2O2. Am J Pathol. 1983 Mar;110(3):297–309. [PMC free article] [PubMed] [Google Scholar]
  46. Williamson J. M., Boettcher B., Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6246–6249. doi: 10.1073/pnas.79.20.6246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Winterbauer R. H., Hammar S. P., Hallman K. O., Hays J. E., Pardee N. E., Morgan E. H., Allen J. D., Moores K. D., Bush W., Walker J. H. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med. 1978 Oct;65(4):661–672. doi: 10.1016/0002-9343(78)90855-0. [DOI] [PubMed] [Google Scholar]
  48. Ziment I. Acetylcysteine: a drug with an interesting past and a fascinating future. Respiration. 1986;50 (Suppl 1):26–30. doi: 10.1159/000195085. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES